Trademarkia Logo

Canada

C$
SUN DESIGN
REGISTERED

on 26 Oct 2022

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2012723 filed on 18th Nov 2019

Registration Number

TMA1147726 registered on 26th Oct 2022

Registration expiry Date

18th Nov 2029

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

SUN DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Vienna Information


1 . 3 . 2

Other representations of the sunAutres représentations du soleil

1 . 3 . 15

Sun with rays constituted by rectilinear lines, sheaves of lines or bandsSoleil à rayons constitués par des traits, des faisceaux de traits ou des bandes rectilignes

1 . 1 . 1

StarsÉtoiles

1 . 1 . 2

One starUne étoile

1 . 1 . 10

Stars with more than four pointsÉtoiles à plus de quatre pointes

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 7

Vertical lines or bandsLignes ou bandes verticales

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals.


Classification kind code

11

Mark Details


Serial Number

2012723

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 19th May 2021
Search Recorded
Submitted for opposition 256
on 21st Dec 2020
Notification of Possible Opposition Sent
Submitted for opposition 130
on 24th Aug 2020
Note to file
Submitted for opposition 257
on 28th May 2020
Designation Notification - Madrid Protocol
Submitted for opposition 257
on 20th Feb 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Feb 2020
Created
Submitted for opposition 31
on 19th Feb 2020
Formalized
Submitted for opposition 30
on 18th Nov 2019
Filed
Submitted for opposition 228
on 18th Nov 2019
International Registration
Submitted for opposition 210
on 18th Nov 2019
IR Correction